Overview

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, crossover study to determine the effect of food when a combination tablet of SYR-322 and metformin hydrochloride ( hereinafter referred to as SYR-322-MET tablet) is orally administered under fasting conditions in the morning or after breakfast in Japanese healthy adult male subjects.

Phase:

Phase 3

Details

Lead Sponsor:

Takeda

Treatments:

Alogliptin
Metformin